Fresenius Medical Care AG (FMS) Stock

Healthcare · Medical Care Facilities · Member of Other US Stocks

Fresenius Medical Care AG (FMS) closed at USD 21.54 on 2026-10-14, a change of -17.3 % over the past year, with a market capitalization of USD 11.78B.

Fresenius Medical Care AG recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Fresenius Medical Care AG key figures

Previous close

USD 21.54 (2026-10-14)

1-year change

-17.3 %

Market cap

USD 11.78B

Enterprise value

USD 22.67B

P/E ratio (trailing)

10.90

P/E ratio (forward)

7.40

EPS (trailing)

2.03

EPS (forward)

2.99

PEG ratio

0.71

Price to book

0.84

Revenue growth

1.4 %

Earnings growth

5.5 %

Dividend per share (trailing)

1.49

Short ratio

3.92

Employees

107,226

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Fresenius Medical Care AG and compare it with other stocks.